Event Details

Verastem Inc at 2013 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer

Sunday, October 27, 2013  through Wednesday, October 30, 2013 
Title
Verastem Inc at 2013 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer
Date / Time
October 27, 2013
Description

Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 as Maintenance Therapy in Subjects with Malignant Pleural Mesothelioma which has Not Progressed on at least 4 Cycles of Pemetrexed/Platinum Therapy (COMMAND)

Abstract #: P2.14-014

Date and Time: Tuesday, October 29, 2013 9:30 – 4:30 PM

Session: Poster Session 2; Mesothelioma

Location: Exhibit Hall, Ground Level

Title: Malignant Mesothelioma Lacking Merlin Shows Enhanced Sensitivity to the FAK Inhibitor VS-6063: Evaluation of Merlin/NF2 Status in Clinical Samples

Abstract #: P2.06-048

Date and Time: Tuesday, October 29, 2013 9:30 – 4:30 PM

Session: Poster Session 2; Prognostic and Predictive Biomarkers

Location: Exhibit Hall, Ground Level